Last reviewed · How we verify

NCT04167254

Sit Down and Play India

Completed Phase 1 Last updated 3 May 2021
What this trial tests

Phase 1 trial testing Sit Down and Play in Development, Child in 59 participants. Completed in 1 April 2021.

Timeline
7 February 2020
Primary endpoint
18 August 2020
1 April 2021

Quick facts

Lead sponsorUniversity of Illinois at Chicago
PhasePhase 1
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designsingle group
Maskingsingle
Primary purposeprevention
Enrollment59
Start date7 February 2020
Primary completion18 August 2020
Estimated completion1 April 2021
Sites2 locations across United States, India

Drugs / interventions tested

Conditions studied

Sponsor

University of Illinois at Chicago

Who can join

18 and older, any sex, with Development, Child. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To gather data essential to evaluate the acceptability and feasibility of a brief, health care-based program delivered in routine healthcare visits in low and low-middle income countries to promote positive parenting behaviors with the aim to support early child development.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Implementing an early childhood development intervention with routine immunization visits in India: a feasibility trial.
    Shah R, Herekar V, Metgud D, Kim H, et al · · 2022 · cited 2× · PMID 35508559 · DOI 10.1007/s00431-022-04485-w

Verify or expand the search:

Other trials of Sit Down and Play

Trials testing the same drug.

Other recruiting trials for Development, Child

Currently open trials in the same condition.

Other University of Illinois at Chicago trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04167254.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing